New South Wales, Australia

Alan Duncan Robertson

USPTO Granted Patents = 13 

Average Co-Inventor Count = 6.3

ph-index = 4

Forward Citations = 68(Granted Patents)


Location History:

  • Melbourne, AU (2005 - 2009)
  • Frenchs Forest, AU (2013)
  • New South Wales, AU (2009 - 2018)
  • Warrawee, AU (2010 - 2021)

Company Filing History:


Years Active: 2005-2021

Loading Chart...
13 patents (USPTO):Explore Patents

Title: Alan Duncan Robertson: Innovator in Amine Oxidase Inhibition

Introduction

Alan Duncan Robertson is an esteemed inventor based in New South Wales, Australia, known for his significant contributions to the field of pharmaceuticals. With a total of 13 patents to his name, Robertson has emerged as a notable figure in the development of treatments for various medical conditions.

Latest Patents

Among his latest innovations are the patents for “Haloallylamine indole and azaindole derivative inhibitors of lysyl oxidases and uses thereof”. This invention details novel compounds that are capable of inhibiting certain amine oxidase enzymes. These compounds demonstrate potential in treating a range of conditions, including fibrosis, cancer, and angiogenesis, applicable to both human patients and veterinary practices involving pets and livestock. Furthermore, the invention encompasses pharmaceutical compositions made from these compounds, expanding their utility in modern medicine.

Career Highlights

Alan has garnered considerable experience through his tenure at prominent companies, including AstraZeneca and Boehringer Ingelheim International GmbH. His work at these organizations not only highlights his expertise in pharmaceutical innovation but also his role in advancing drug development.

Collaborations

Robertson has collaborated with various professionals throughout his career, notably with colleagues like Alison Dorothy Findlay and Jonathan Stuart Foot. These collaborations have contributed to the depth and breadth of his research, promoting innovation within the pharmaceutical sector.

Conclusion

In conclusion, Alan Duncan Robertson stands out as a prolific inventor whose patents reflect his commitment to improving healthcare outcomes. His contributions to the pharmaceutical field, particularly through the inhibition of amine oxidase enzymes, demonstrate the impact of innovative thinking in addressing complex medical challenges. Through his ongoing research and collaborations, Robertson continues to inspire future advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…